Top
FEZF2 has not been detected as a mutational cancer driver

FEZF2
Ensembl id ENSG00000153266
Mutated samples
Coding Sequence 28 (0.4%)
Protein Affecting 21 (0.3%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all FEZF2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Breast carcinoma No 4 3 0.26
Lung squamous cell carcinoma No 5 3 1.72
Cutaneous melanoma No 4 3 0.81
Lung adenocarcinoma No 2 2 0.51
Colorectal adenocarcinoma No 3 2 0.87
Bladder carcinoma No 1 1 1.02
Acute myeloid leukemia No 1 1 0.51
Uterine corpus endometrioid carcinoma No 1 1 0.43
Non small cell lung carcinoma No 1 1 3.23
Stomach adenocarcinoma No 2 1 0.62
Small cell lung carcinoma No 1 1 1.45
Head and neck squamous cell carcinoma No 1 1 0.27
Esophageal carcinoma No 1 1 0.68
Medulloblastoma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence